<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=9348104" created="08/06/2006" creator="Noriko Katsu"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>9348104</PMID>
<Article>
<ArticleTitle>
<sentence id="S1"><term id="T1" lex="helenalin" sem="Organic_compound_other">Helenalin</term>, an <term id="T2" lex="anti-inflammatory_sesquiterpene_lactone" sem="Organic_compound_other">anti-inflammatory sesquiterpene lactone</term> from <term id="T3" lex="Arnica" sem="Multicellular_organism_natural">Arnica</term>, selectively inhibits <term id="T4" lex="transcription_factor" sem="Protein_family_or_group">transcription factor</term> <term id="T5" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term> [see comments]</sentence>
<event id="E1">
<type class="Negative_regulation"/>
<theme idref="T5"/>
<cause idref="T1"/>
<clue>Helenalin, an anti-inflammatory sesquiterpene lactone from Arnica, selectively <clueType>inhibits</clueType> transcription factor NF-kappaB [see comments]</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2"><term id="A1" sem="Organic_compound_other"><term id="T6" lex="alcoholic_extract" sem="Organic_compound_other">Alcoholic extracts</term> prepared form <term id="T7" lex="Arnicae_flos" sem="Multicellular_organism_natural">Arnicae flos</term></term>, the collective name for <term id="T8" lex="flowerhead" sem="Body_region">flowerheads</term> from <term id="T9" lex="Arnica_montana" sem="Multicellular_organism_natural">Arnica montana</term> and <term id="T10" lex="A._chamissonis" sem="Body_region">A. chamissonis</term> ssp. foliosa, are used therapeutically as <term id="T11" lex="anti-inflammatory_remedy" sem="Other">anti-inflammatory remedies</term>.</sentence>
<event KT="Fact" id="E2">
<type class="Negative_regulation"/>
<cause idref="A1"/>
<clue>Alcoholic extracts prepared form Arnicae flos, the collective name for flowerheads from Arnica montana and A. chamissonis ssp. foliosa, are used therapeutically as <clueType>anti-inflammatory</clueType> remedies.</clue>
<comment>TPS: A1</comment></event>
<sentence id="S3">The active ingredients mediating the <term id="T12" lex="pharmacological_effect" sem="Other">pharmacological effect</term> are mainly <term id="T13" lex="sesquiterpene_lactone" sem="Organic_compound_other">sesquiterpene lactones</term>, such as <term id="T14" lex="helenalin" sem="Organic_compound_other">helenalin</term>, <term id="T15" lex="11alpha,13-dihydrohelenalin" sem="Organic_compound_other">11alpha,13-dihydrohelenalin</term>, <term id="T16" lex="chamissonolid" sem="Organic_compound_other">chamissonolid</term> and their <term id="T17" lex="ester_derivative" sem="Organic_compound_other">ester derivatives</term>.</sentence>
<event KT="Fact" id="E3">
<type class="Positive_regulation"/>
<theme idref="T12"/>
<cause idref="T14"/>
<clue>The active ingredients <clueType>mediating</clueType> the pharmacological effect are mainly <corefCause>sesquiterpene lactones</corefCause>, such as helenalin, 11alpha,13-dihydrohelenalin, chamissonolid and their ester derivatives.</clue>
</event>
<event KT="Fact" id="E4">
<type class="Positive_regulation"/>
<theme idref="T12"/>
<cause idref="T15"/>
<clue>The active ingredients <clueType>mediating</clueType> the pharmacological effect are mainly <corefCause>sesquiterpene lactones</corefCause>, such as helenalin, 11alpha,13-dihydrohelenalin, chamissonolid and their ester derivatives.</clue>
</event>
<event KT="Fact" id="E5">
<type class="Positive_regulation"/>
<theme idref="T12"/>
<cause idref="T16"/>
<clue>The active ingredients <clueType>mediating</clueType> the pharmacological effect are mainly <corefCause>sesquiterpene lactones</corefCause>, such as helenalin, 11alpha,13-dihydrohelenalin, chamissonolid and their ester derivatives.</clue>
</event>
<event KT="Fact" id="E6">
<type class="Positive_regulation"/>
<theme idref="T12"/>
<cause idref="T17"/>
<clue>The active ingredients <clueType>mediating</clueType> the pharmacological effect are mainly <corefCause>sesquiterpene lactones</corefCause>, such as helenalin, 11alpha,13-dihydrohelenalin, chamissonolid and their ester derivatives.</clue>
</event>
<sentence id="S4">While these compounds affect various <term id="T18" lex="cellular_process" sem="Other">cellular processes</term>, current data do not fully explain how <term id="T19" lex="sesquiterpene_lactone" sem="Organic_compound_other">sesquiterpene lactones</term> exert their <term id="T20" lex="anti-inflammatory_effect" sem="Other">anti-inflammatory effect</term>.</sentence>
<event KT="Fact" id="E7">
<type class="Regulation"/>
<theme idref="T18"/>
<cause idref="T19"/>
<clue>While <corefCause>these compounds</corefCause> <clueType>affect</clueType> various cellular processes, current data do not fully explain how sesquiterpene lactones exert their anti-inflammatory effect.</clue>
</event>
<event KT="Other" id="E8" uncertainty="doubtful">
<type class="Regulation"/>
<cause idref="T19"/>
<clue>While these compounds affect various cellular processes, current data do not fully explain how sesquiterpene lactones <clueType>exert</clueType> <corefCause>their</corefCause> <clueType>anti-inflammatory effect</clueType>.</clue>
<comment>NO THEME</comment></event>
<sentence id="S5">We show here that <term id="T21" lex="helenalin" sem="Organic_compound_other">helenalin</term>, and, to a much lesser degree, <term id="T22" lex="11alpha,13-dihydrohelenalin" sem="Organic_compound_other">11alpha,13-dihydrohelenalin</term> and <term id="T23" lex="chamissonolid" sem="Organic_compound_other">chamissonolid</term>, inhibit activation of <term id="T24" lex="transcription_factor" sem="Protein_family_or_group">transcription factor</term> <term id="T25" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term>.</sentence>
<event KT="Analysis" id="E9">
<type class="Negative_regulation"/>
<theme idref="E12"/>
<cause idref="T21"/>
<clue>We <clueKT>show</clueKT> here that helenalin, and, to a much lesser degree, 11alpha,13-dihydrohelenalin and chamissonolid, <clueType>inhibit</clueType> activation of transcription factor NF-kappaB.</clue>
</event>
<event KT="Analysis" Manner="Low" id="E10">
<type class="Negative_regulation"/>
<theme idref="E12"/>
<cause idref="T22"/>
<clue>We <clueKT>show</clueKT> here that helenalin, and, <clueManner>to a much lesser degree</clueManner>, 11alpha,13-dihydrohelenalin and chamissonolid, <clueType>inhibit</clueType> activation of transcription factor NF-kappaB.</clue>
</event>
<event KT="Analysis" Manner="Low" id="E11">
<type class="Negative_regulation"/>
<theme idref="E12"/>
<cause idref="T23"/>
<clue>We <clueKT>show</clueKT> here that helenalin, and, <clueManner>to a much lesser degree</clueManner>, 11alpha,13-dihydrohelenalin and chamissonolid, <clueType>inhibit</clueType> activation of transcription factor NF-kappaB.</clue>
</event>
<event KT="Other" id="E12">
<type class="Positive_regulation"/>
<theme idref="T25"/>
<clue>We show here that helenalin, and, to a much lesser degree, 11alpha,13-dihydrohelenalin and chamissonolid, inhibit <clueType>activation</clueType> <linkTheme>of</linkTheme> transcription factor NF-kappaB.</clue>
</event>
<sentence id="S6">This difference in efficacy, which correlates with the compounds&apos; <term id="T26" lex="anti-inflammatory_potency" sem="Other">anti-inflammatory potency</term> in vivo, may be explained by differences in structure and conformation.</sentence>
<sentence id="S7"><term id="T27" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term>, which resides in an inactive, <term id="T28" lex="cytoplasmic_complex" sem="Protein_complex">cytoplasmic complex</term> in <term id="T29" lex="unstimulated_cell" sem="Cell_cultured">unstimulated cells</term>, is activated by <term id="T30" lex="phosphorylation" sem="Other">phosphorylation</term> and <term id="T31" lex="degradation" sem="Other">degradation</term> of its <term id="T32" lex="inhibitory_subunit" sem="Protein_molecule">inhibitory subunit</term>, <term id="T33" lex="IkappaB" sem="Protein_molecule">IkappaB</term>.</sentence>
<event KT="Fact" id="E14">
<type class="Positive_regulation"/>
<theme idref="T27"/>
<cause idref="E16"/>
<clue>NF-kappaB, which resides in an inactive, <clueLoc>cytoplasmic</clueLoc> complex in unstimulated cells, is <clueType>activated</clueType> <linkCause>by</linkCause> phosphorylation and degradation of its inhibitory subunit, IkappaB.</clue>
</event>
<event KT="Fact" id="E15">
<type class="Positive_regulation"/>
<theme idref="T27"/>
<cause idref="E17"/>
<clue>NF-kappaB, which resides in an inactive, <clueLoc>cytoplasmic</clueLoc> complex in unstimulated cells, is <clueType>activated</clueType> <linkCause>by</linkCause> phosphorylation and degradation of its inhibitory subunit, IkappaB.</clue>
</event>
<event KT="Other" id="E16">
<type class="Protein_amino_acid_phosphorylation"/>
<theme idref="T33"/>
<clue>NF-kappaB, which resides in an inactive, cytoplasmic complex in unstimulated cells, is activated by <clueType>phosphorylation</clueType> and degradation <linkTheme>of</linkTheme> its inhibitory subunit, IkappaB.</clue>
</event>
<event KT="Other" id="E17">
<type class="Protein_catabolism"/>
<theme idref="T33"/>
<clue>NF-kappaB, which resides in an inactive, cytoplasmic complex in unstimulated cells, is activated by phosphorylation and <clueType>degradation</clueType> <linkTheme>of</linkTheme> its inhibitory subunit, IkappaB.</clue>
</event>
<sentence id="S8"><term id="T34" lex="helenalin" sem="Organic_compound_other">Helenalin</term> inhibits <term id="T35" lex="NF-kappaB_activation" sem="Other"><term id="T36" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term> activation</term> in response to four different <term id="A2" sem="Other">stimuli</term> in <term id="T37" lex="T-cell" sem="Cell_natural">T-cells</term>, <term id="T38" lex="B-cell" sem="Cell_natural">B-cells</term> and <term id="T39" lex="epithelial_cell" sem="Cell_natural">epithelial cells</term> and abrogates <term id="T41" lex="kappaB" sem="Protein_molecule">kappaB</term>-driven <term id="A3" sem="Other">gene expression</term>.</sentence>
<event KT="Fact" id="E18">
<type class="Negative_regulation"/>
<theme idref="E19"/>
<cause idref="T34"/>
<clue>Helenalin <clueType>inhibits</clueType> NF-kappaB activation in response to four different stimuli <clueLoc>in T-cells, B-cells and epithelial cells</clueLoc> and abrogates kappaB-driven gene expression.</clue>
</event>
<event KT="Other" id="E19">
<type class="Positive_regulation"/>
<theme idref="T36"/>
<cause idref="A2"/>
<clue>Helenalin inhibits NF-kappaB <clueType>activation</clueType> <linkCause>in response to</linkCause> four different stimuli <clueLoc>in T-cells, B-cells and epithelial cells</clueLoc> and abrogates kappaB-driven gene expression.</clue>
</event>
<event KT="Fact" id="E20">
<type class="Negative_regulation"/>
<theme idref="E21"/>
<cause idref="T34"/>
<clue>Helenalin inhibits NF-kappaB activation in response to four different stimuli in T-cells, B-cells and epithelial cells and <clueType>abrogates</clueType> kappaB-driven gene expression.</clue>
</event>
<event KT="Other" id="E21">
<type class="Positive_regulation"/>
<theme idref="A3"/>
<cause idref="T41"/>
<clue>Helenalin inhibits NF-kappaB activation in response to four different stimuli in T-cells, B-cells and epithelial cells and abrogates kappaB-<clueType>driven</clueType> gene expression.</clue>
</event>
<sentence id="S9">This inhibition is selective, as the activity of four other <term id="T42" lex="transcription_factor" sem="Protein_family_or_group">transcription factors</term>, <term id="T43" lex="Oct-1" sem="Protein_molecule">Oct-1</term>, <term id="T44" lex="TBP" sem="Protein_molecule">TBP</term>, <term id="T45" lex="Sp1" sem="Protein_molecule">Sp1</term> and <term id="T46" lex="STAT_5" sem="Protein_molecule">STAT 5</term> was not affected.</sentence>
<event Polarity="Negative" assertion="non-exist" id="E26">
<type class="Regulation"/>
<theme idref="T43"/>
<cause idref="T34"/>
<clue>This inhibition is selective, as the activity of four other transcription factors, Oct-1, TBP, Sp1 and STAT 5 was <cluePolarity>not</cluePolarity> <clueType>affected</clueType>.</clue>
<comment>NO COREFCAUSE</comment></event>
<event Polarity="Negative" assertion="non-exist" id="E27">
<type class="Regulation"/>
<theme idref="T44"/>
<cause idref="T34"/>
<clue>This inhibition is selective, as the activity of four other transcription factors, Oct-1, TBP, Sp1 and STAT 5 was <cluePolarity>not</cluePolarity> <clueType>affected</clueType>.</clue>
<comment>NO COREFCAUSE</comment></event>
<event Polarity="Negative" assertion="non-exist" id="E28">
<type class="Regulation"/>
<theme idref="T45"/>
<cause idref="T34"/>
<clue>This inhibition is selective, as the activity of four other transcription factors, Oct-1, TBP, Sp1 and STAT 5 was <cluePolarity>not</cluePolarity> <clueType>affected</clueType>.</clue>
<comment>NO COREFCAUSE</comment></event>
<event Polarity="Negative" assertion="non-exist" id="E29">
<type class="Regulation"/>
<theme idref="T46"/>
<cause idref="T34"/>
<clue>This inhibition is selective, as the activity of four other transcription factors, Oct-1, TBP, Sp1 and STAT 5 was <cluePolarity>not</cluePolarity> <clueType>affected</clueType>.</clue>
<comment>NO COREFCAUSE</comment></event>
<sentence id="S10">We show that inhibition is not due to a direct modification of the active <term id="T47" lex="NF-kappaB_heterodimer" sem="Protein_complex"><term id="T48" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term> heterodimer</term>.</sentence>
<event KT="Analysis" Polarity="Negative" assertion="non-exist" id="E30">
<type class="Positive_regulation"/>
<theme idref="E18"/>
<cause idref="E31"/>
<clue>We <clueKT>show</clueKT> that <corefTheme>inhibition</corefTheme> is <cluePolarity>not</cluePolarity> <clueType>due</clueType> <linkCause>to</linkCause> a direct modification of the active NF-kappaB heterodimer.</clue>
</event>
<event KT="Other" id="E31">
<type class="Regulation"/>
<theme idref="T47"/>
<clue>We show that inhibition is not due to a direct <clueType>modification</clueType> <linkTheme>of</linkTheme> the active NF-kappaB heterodimer.</clue>
</event>
<sentence id="S11">Rather, <term id="T49" lex="helenalin" sem="Organic_compound_other">helenalin</term> modifies the <term id="T50" lex="NF-kappaB/IkappaB_complex" sem="Protein_complex"><term id="A4" sem="Protein_complex">NF-kappaB</term>/<term id="T51" lex="IkappaB" sem="Protein_molecule">IkappaB</term> complex</term>, preventing the release of <term id="T52" lex="IkappaB" sem="Protein_molecule">IkappaB</term>.</sentence>
<event id="E32">
<type class="Regulation"/>
<theme idref="T50"/>
<cause idref="T49"/>
<clue>Rather, helenalin <clueType>modifies</clueType> the NF-kappaB/IkappaB complex, preventing the release of IkappaB.</clue>
</event>
<event KT="Other" id="E34">
<type class="Localization"/>
<theme idref="T52"/>
<clue>Rather, helenalin modifies the NF-kappaB/IkappaB complex, preventing the <clueType>release</clueType> <linkTheme>of</linkTheme> IkappaB.</clue>
</event>
<event id="E35">
<type class="Negative_regulation"/>
<theme idref="E34"/>
<cause idref="E32"/>
<clue>Rather, helenalin modifies the NF-kappaB/IkappaB complex, <clueType>preventing</clueType> the release of IkappaB.</clue>
</event>
<sentence id="S12">These data suggest a molecular mechanism for the <term id="T53" lex="anti-inflammatory_effect" sem="Other">anti-inflammatory effect</term> of <term id="T54" lex="sesquiterpene_lactone" sem="Organic_compound_other">sesquiterpene lactones</term>, which differs from that of other <term id="T55" lex="nonsteroidal_anti-inflammatory_drug" sem="Organic_compound_other">nonsteroidal anti-inflammatory drugs</term> (<term id="T56" lex="NSAID" sem="Organic_compound_other">NSAIDs</term>), <term id="T57" lex="indomethacin" sem="Organic_compound_other">indomethacin</term> and <term id="T58" lex="acetyl_salicylic_acid" sem="Organic_compound_other">acetyl salicylic acid</term>.</sentence>
<event CL="L2" KT="Analysis" id="E36">
<type class="Negative_regulation"/>
<cause idref="T54"/>
<clue>These data <clueKT><clueCL>suggest</clueCL></clueKT> a molecular mechanism for the <clueType>anti-inflammatory effect</clueType> <linkCause>of</linkCause> sesquiterpene lactones, which differs from that of other nonsteroidal anti-inflammatory drugs (NSAIDs), indomethacin and acetyl salicylic acid.</clue>
<comment>NO THEME</comment></event>
<event CL="L2" KT="Analysis" id="E39">
<type class="Negative_regulation"/>
<cause idref="T57"/>
<clue>These data <clueKT><clueCL>suggest</clueCL></clueKT> a molecular mechanism for the <clueType>anti-inflammatory effect</clueType> of sesquiterpene lactones, which differs from that <linkCause>of</linkCause> <corefCause>other nonsteroidal anti-inflammatory drugs (NSAIDs)</corefCause>, indomethacin and acetyl salicylic acid.</clue>
<comment>NO THEME</comment></event>
<event CL="L2" KT="Analysis" id="E40">
<type class="Negative_regulation"/>
<cause idref="T58"/>
<clue>These data <clueKT><clueCL>suggest</clueCL></clueKT> a molecular mechanism for the <clueType>anti-inflammatory effect</clueType> of sesquiterpene lactones, which differs from that <linkCause>of</linkCause> <corefCause>other nonsteroidal anti-inflammatory drugs (NSAIDs)</corefCause>, indomethacin and acetyl salicylic acid.</clue>
<comment>NO THEME</comment></event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
